MEDVi
Reviews 2026: Real Customer Experiences, Pricing, and Safety
Concerns

Quick Answer

MEDVi is a telehealth platform offering compounded GLP-1 medications (semaglutide and tirzepatide) for weight loss starting at $179 per month. With a 4.5 out of 5 “Excellent” rating on Trustpilot, MEDVi has helped thousands of customers access affordable weight loss medication. The service provides a convenient, accessible option for those looking to start GLP-1 therapy without the $1,000+ monthly cost of brand-name options like Wegovy or Zepbound. Like all compounded medications, these formulations are not FDA-approved, which is an important consideration for prospective users.

What Is MEDVi?

MEDVi is a direct-to-consumer telehealth platform specializing in
weight loss through GLP-1 receptor agonist medications. The company
provides compounded versions of semaglutide (the active ingredient in
Ozempic and Wegovy) and tirzepatide (found in Mounjaro and Zepbound)
through online consultations with board-certified physicians.

Unlike traditional telehealth services that prescribe brand-name
medications, MEDVi works with compounding pharmacies to create custom
formulations of these GLP-1 drugs. This approach significantly reduces
costs, making medications that typically cost over $1,000 per month
available for under $200.

The service launched during the widespread GLP-1 shortage that began
in 2022. FDA regulations allow compounding pharmacies to produce
versions of drugs experiencing supply shortages. Brand-name
manufacturers have largely resolved these shortages, but compounding
telehealth companies continue operating under ongoing legal and
regulatory scrutiny.

How MEDVi Works

The MEDVi process follows a standard telehealth model designed for
convenience and accessibility:

Step 1: Online
Health Assessment (5-10 minutes)

Patients complete a comprehensive digital intake form covering
medical history, current medications, weight loss goals, and eligibility
criteria. The questionnaire screens for contraindications like personal
or family history of medullary thyroid carcinoma or multiple endocrine
neoplasia syndrome type 2.

Step 2: Physician
Review and Consultation

A licensed, board-certified U.S. physician reviews the submitted
information. MEDVi claims most reviews occur within 24-48 hours. If
approved, the physician creates a personalized treatment plan including
medication type (semaglutide or tirzepatide), dosage, and titration
schedule.

According to user reports on Reddit, some consultations are
asynchronous (messaging only), while others may include brief video
calls depending on medical complexity and state regulations.

Step 3: Prescription and
Compounding

Once approved, the prescription is sent to MEDVi’s partner
compounding pharmacy. The pharmacy prepares the medication according to
the prescribed dosage and ships directly to the patient’s address.

Step 4: Medication Delivery
(2-7 days)

MEDVi ships medications with ice packs to maintain proper storage
temperatures during transit. Injectable formulations arrive with
syringes, alcohol wipes, and detailed administration instructions.
Tablet formulations (where available) come in marked dosing
packages.

Step 5: Ongoing Support
and Adjustments

Patients receive access to 24/7 messaging with medical providers for
questions, dosage adjustments, or side effect management. Monthly
refills are automatically processed unless patients cancel their
subscription.

MEDVi Pricing and Costs

MEDVi advertises starting prices around $179 per month, which makes
it one of the cheaper compounded GLP-1 options. Actual costs vary based
on medication type, dosage, and format.

What’s Included

• Medical consultation and physician review
• Prescribed GLP-1 medication (one month supply)
• Shipping and handling
• Syringes and supplies (for injectable versions)
• 24/7 provider messaging access
• Metabolic and nutrition reports (according to marketing
  materials)

How MEDVi Pricing Compares

Provider	Monthly Cost	Medication Type	FDA Status
MEDVi	$179+	Compounded semaglutide/tirzepatide	Not FDA-approved
Henry Meds	$197-$297	Compounded semaglutide	Not FDA-approved
Hims & Hers	$199+	Compounded GLP-1s	Not FDA-approved
Ro (Wegovy)	$199-$349	Brand-name semaglutide	FDA-approved
Brand-name (no insurance)	$1,000-$1,400	Wegovy/Zepbound	FDA-approved

Hidden Costs to Consider

• No insurance accepted: MEDVi is cash-only, meaning
  no insurance reimbursement
• HSA/FSA eligibility: Can be used but requires
  documentation
• Commitment periods: Some Reddit users report
  pressure to commit to multi-month plans
• Cancellation complexity: Multiple reports of
  difficulty obtaining refunds after cancellation

Is MEDVi Legit?
Safety and Regulatory Status

This question has no simple yes-or-no answer. MEDVi operates legally
under current FDA compounding regulations. But “legal” and “safe as
brand-name medications” are two different things.

The Compounding Distinction

Compounded medications are not FDA-approved. This is
not unique to MEDVi but applies to all compounded GLP-1 providers. The
FDA explicitly states that compounded drugs “do not undergo FDA’s review
for safety, effectiveness, and quality before they are marketed.”

According to FDA guidance, compounded drugs should only be used when:
– An FDA-approved drug cannot meet a patient’s medical needs, or – The
FDA-approved drug is not commercially available due to shortage

With Wegovy and Zepbound now widely available, the justification for
compounded GLP-1s has become less clear, leading to ongoing regulatory
scrutiny.

FDA Safety
Concerns Specific to Compounded GLP-1s

The FDA has documented several concerning issues with compounded
semaglutide and tirzepatide across the industry:

1. Improper Storage During Shipping

Injectable GLP-1 medications require refrigeration. The FDA has
received complaints about compounded products “arriving warm or with
inadequate ice packs.” The agency warns patients not to use any
injectable GLP-1 that arrives improperly stored, as temperature exposure
compromises drug quality and effectiveness.

2. Dosing Errors Leading to Hospitalization

As of July 31, 2025, the FDA received: – 605 reports of adverse
events associated with compounded semaglutide – 545 reports of adverse
events associated with compounded tirzepatide

Some adverse events required hospitalization due to dosing errors
from patients measuring incorrect doses or physicians miscalculating
titration schedules. Common symptoms included severe nausea, vomiting,
diarrhea, abdominal pain, constipation, and dehydration.

3. Fraudulent Products and Mislabeling

The FDA identified fraudulent compounded semaglutide and tirzepatide
with false pharmacy information on labels. In some cases, the
compounding pharmacies listed don’t exist; in others, legitimate
pharmacies’ names were used without authorization.

4. Use of Unauthorized Salt Forms

Some compounders use semaglutide sodium or semaglutide acetate
instead of the base form used in FDA-approved drugs. The FDA states it
“does not have information on whether these salts have the same chemical
and pharmacologic properties” and is “not aware of any lawful basis for
their use in compounding.”

What Makes a
Compounding Pharmacy Trustworthy?

Not all compounding pharmacies operate at the same quality standards.
Reputable operations should: – Be licensed in their state and registered
with the FDA – Operate as a 503B outsourcing facility (higher regulatory
standard) – Source ingredients from FDA-inspected manufacturers –
Conduct sterility and potency testing – Maintain proper cold chain
logistics – Provide clear dosing instructions and measuring tools

MEDVi does not publicly disclose which compounding pharmacy or
pharmacies it partners with, making it difficult for patients to
independently verify quality standards.

Real Customer Reviews and
Experiences

To understand MEDVi’s actual performance, we examined verified
customer reviews from Trustpilot and detailed user experiences shared on
Reddit.

Trustpilot Rating: 4.5
out of 5 (Excellent)

MEDVi has a 4.5 out of 5 rating on Trustpilot based on verified
customer reviews. Trustpilot labels this “Excellent.” Positive themes
from verified reviews include:

• Affordability: Customers consistently mention cost
  savings versus brand-name options
• Accessibility: Straightforward online process
  without insurance requirements
• Physician quality: Many reviewers mention helpful,
  responsive doctors
• Effectiveness: Users report weight loss of 15-30+
  pounds
• Fast shipping: Medications typically arrive within
  2-5 days

Reddit Experiences: A
More Complex Picture

Reddit’s r/tirzepatidecompound community reveals more nuanced
experiences with MEDVi, including both success stories and serious
complaints.

Positive Experiences:

One user posted a “10-month review” reporting successful weight loss,
responsive customer service, and no major issues. They defended MEDVi
against critics, noting that “it doesn’t make them a scam if they have
100k+ customers and a percentage have bad experiences.”

Common Complaints:

1. Refund Policy Changes: Multiple users report
   that MEDVi advertised a money-back guarantee if no weight loss occurred
   after 3 months, then changed the policy to 5 months after customers
   requested refunds. One user stated MEDVi refused a refund because they
   had “fluctuated by 1lb,” claiming any weight change disqualified
   them.

2. Billing Issues: Several reports of unauthorized
   refills being charged. One user titled their post “[WARNING] My
   experience with MEDVi – bait-and-switch prescription + shifting refund
   amounts.”

3. Customer Service Difficulties: Multiple users
   report contacting customer service “approximately 50 times between
   emails and phone calls” with poor resolution. Some customers filed
   complaints with the Better Business Bureau, Consumer Affairs, and
   FTC.

4. Product Quality Concerns: A small number of
   users questioned medication potency, though these are difficult to
   verify without independent testing.

Quote from a detailed negative review: > “All the
reviews regarding not refunding after canceling your subscription are
true. Company acts very entitled and refuses to acknowledge their
mistakes. Customer service is poor. Read reviews on Consumer Affairs and
Google. The disappointment is real.”

Balanced Assessment

MEDVi successfully serves many customers, as the Trustpilot rating
shows. But Reddit complaints reveal patterns around refund policies,
billing practices, and customer service that potential customers should
know about. The gap between positive Trustpilot reviews and critical
Reddit posts suggests experiences vary significantly.

MEDVi Pros and Cons

Pros

• Affordable pricing: $179/month versus $1,000+ for
  brand-name options
• No insurance required: Accessible to those without
  coverage or high deductibles
• Board-certified physicians: Licensed U.S. doctors
  oversee prescriptions
• Fast delivery: 2-5 day shipping with most
  orders
• 24/7 provider messaging: Medical support available
  for questions
• HSA/FSA eligible: Can use pre-tax healthcare
  dollars
• Includes support materials: Metabolic reports and
  meal planning resources
• Medication options: Both semaglutide and
  tirzepatide available

Cons

• Not FDA-approved: Compounded formulations lack
  rigorous FDA safety review
• Safety concerns: FDA has documented issues with
  compounded GLP-1s industry-wide
• Pharmacy transparency: MEDVi doesn’t publicly
  disclose compounding partners
• Customer service complaints: Multiple Reddit
  reports of poor support and refund issues
• No insurance reimbursement: Entirely out-of-pocket
  with no claims filing
• Unclear refund policy: Customers report changing
  guarantee terms
• Limited clinical oversight: Mostly asynchronous
  care vs. traditional doctor visits
• Storage risks: Potential temperature control issues
  during shipping

How MEDVi Compares to
Alternatives

MEDVi vs. Ro

Ro offers both compounded and brand-name GLP-1
medications, with Wegovy starting at $199/month for the first two months
(promotional pricing through March 2026), then $349/month.

• Price winner: MEDVi ($179 vs. $199-$349)
• FDA approval: Ro offers FDA-approved Wegovy; MEDVi
  only compounded
• Transparency: Ro clearly distinguishes brand
  vs. compounded options
• Best for: Those wanting FDA-approved medications
  should choose Ro; budget-focused individuals may prefer MEDVi

MEDVi vs. Henry Meds

Henry Meds specializes in compounded GLP-1s with
semaglutide starting at $197-$297/month depending on dosage.

• Price winner: MEDVi (slightly cheaper starting
  price)
• Medication options: Both offer compounded
  semaglutide and tirzepatide
• Reputation: Henry Meds has fewer Reddit complaints
  about billing/refunds
• Best for: Similar target market; choice may come
  down to customer service reputation

MEDVi vs. Hims & Hers

Hims & Hers recently launched aggressive pricing
for compounded GLP-1s, with oral semaglutide starting at $49/month
(first month) then $99/month for 5-month plans. Injectables start at
$199/month.

• Price winner: Hims & Hers (especially for oral
  formulations)
• Format options: Hims & Hers offers more oral
  options; MEDVi focuses on injectables
• Brand recognition: Hims & Hers is a
  publicly-traded company with more established presence
• Best for: Those interested in oral formulations
  should explore Hims & Hers

MEDVi vs. Brand-Name
(Wegovy/Zepbound)

Brand-name medications cost $1,000-$1,400/month
without insurance but are FDA-approved with extensive clinical trial
data.

• Price winner: MEDVi (6-8x cheaper)
• Safety profile: Brand-name medications have
  comprehensive FDA review
• Insurance coverage: Brand-name may be covered;
  compounded never is
• Clinical data: Brand-name has extensive trial data;
  compounded does not
• Best for: Those with insurance coverage should
  pursue brand-name; those paying cash may consider compounded
  alternatives while understanding trade-offs

Does MEDVi Actually
Work? Expected Results

The medications MEDVi provides (semaglutide and tirzepatide) are
based on compounds with strong clinical evidence for weight loss when
produced as FDA-approved drugs.

Clinical Trial Data
(Brand-Name Versions)

Semaglutide (Wegovy): – Average weight loss: 15-17%
of body weight over 68 weeks – Clinical trial participants lost
approximately 34 pounds on average – Source: STEP trial program
published in New England Journal of Medicine

Tirzepatide (Zepbound): – Average weight loss:
15-21% of body weight (dose-dependent) – Clinical trial participants
lost up to 52 pounds on average at highest doses – Source: SURMOUNT
trial program published in JAMA

Real-World Results from
MEDVi Users

Based on Trustpilot and Reddit reviews, MEDVi customers report: –
Noticeable appetite suppression within 1-2 weeks – Initial weight loss
of 5-10 pounds in the first month – Long-term weight loss of 15-30+
pounds over 3-6 months – Plateau periods requiring dosage
adjustments

Important Caveats

The effectiveness of compounded versions depends on: 1.
Accurate compounding: Medications must contain the
correct active ingredient at proper potency 2. Proper
storage: Temperature exposure during shipping can degrade
effectiveness 3. Correct dosing: Users must accurately
measure and administer doses 4. Individual response:
Results vary based on genetics, diet, exercise, and adherence

While many users report successful weight loss with MEDVi, the lack
of FDA oversight means potency and consistency cannot be independently
verified as they are with brand-name medications.

Side Effects and Safety
Considerations

GLP-1 medications produce predictable side effects regardless of
whether they’re brand-name or compounded. However, compounded versions
carry additional risks.

Common GLP-1 Side Effects

• Gastrointestinal issues: Nausea, vomiting,
  diarrhea, constipation (60-70% of users)
• Decreased appetite: Intentional effect but may
  become excessive
• Fatigue and headaches: Especially during titration
  phase
• Injection site reactions: Redness, swelling, or
  itching

These side effects typically diminish as the body adjusts to the
medication, usually within 4-8 weeks.

Serious Risks (Rare)

• Pancreatitis: Inflammation of the pancreas
• Gallbladder problems: Including gallstones
• Thyroid tumors: Black box warning for medullary
  thyroid carcinoma risk
• Hypoglycemia: Especially in patients taking
  diabetes medications
• Kidney problems: From severe dehydration due to
  gastrointestinal side effects

Compounding-Specific
Concerns

In addition to standard GLP-1 risks, compounded versions carry: –
Potency variability: May be over-potent (increasing
side effects) or under-potent (reducing effectiveness) –
Contamination risk: Lower quality control compared to
FDA-approved facilities – Storage degradation:
Temperature exposure during shipping compromises drug stability –
Dosing errors: Self-measuring from vials increases risk
of incorrect dosing

Who Should Avoid MEDVi

• Personal or family history of medullary thyroid carcinoma or MEN2
  syndrome
• Pregnant or breastfeeding individuals
• History of pancreatitis
• Severe gastrointestinal disease
• Those with insurance coverage for brand-name alternatives
• Anyone uncomfortable with compounded medication risks

Frequently Asked Questions

Is MEDVi FDA approved?

No. MEDVi provides compounded medications that are not FDA-approved.
The FDA does not review compounded drugs for safety, effectiveness, or
quality before marketing. This applies to all compounding telehealth
providers, not just MEDVi.

How much does MEDVi cost per
month?

MEDVi starts at $179 per month, though exact pricing varies by
medication type (semaglutide vs. tirzepatide), dosage, and format
(injection vs. tablet where available).

Does MEDVi accept insurance?

No. MEDVi is a cash-pay program that does not accept insurance or
file claims. However, you may be able to use HSA/FSA funds for
payment.

Is MEDVi the same as
Wegovy or Ozempic?

No. MEDVi provides compounded semaglutide, which contains the same
active ingredient as Wegovy and Ozempic but is not manufactured by Novo
Nordisk and is not FDA-approved. The compounded version may have
different inactive ingredients, potency levels, and quality
standards.

How long does MEDVi shipping
take?

Most customers report receiving medications within 2-5 days. MEDVi
ships with ice packs to maintain refrigeration during transit.

Can I cancel MEDVi at any
time?

According to company policy, yes. However, multiple Reddit users
report difficulty obtaining refunds after cancellation, particularly
regarding MEDVi’s money-back guarantee. Read cancellation terms
carefully before committing.

What if MEDVi doesn’t work for
me?

MEDVi has advertised a money-back guarantee, though specific terms
appear unclear based on customer complaints. Multiple users report the
guarantee period changed from 3 to 5 months, and that any weight
fluctuation (even 1 pound) disqualified them from refunds. Clarify
refund terms directly with MEDVi before starting.

Are there alternatives to
MEDVi?

Yes. Alternatives include: – Other compounding
providers: Henry Meds, Hims & Hers, Ro (compounded options)
– Brand-name with insurance: Wegovy, Zepbound through
traditional prescriptions – Lower-cost brands: Ro
offers promotional Wegovy pricing – Non-GLP-1 options:
Contrave, phentermine, or lifestyle-based programs

Is compounded semaglutide
safe?

Compounded semaglutide carries the same inherent medication risks as
brand-name semaglutide, plus additional risks from: – Lack of FDA
quality oversight – Potential potency variability – Storage and shipping
concerns – Increased dosing error risk

The FDA has documented over 600 adverse events associated with
compounded semaglutide as of July 2025. While many customers use
compounded versions without serious issues, the safety profile is less
established than FDA-approved alternatives.

How do I contact MEDVi
customer service?

MEDVi provides 24/7 messaging through their patient portal. Based on
Reddit reports, some customers experienced difficulty reaching
responsive support. The company does not prominently list phone numbers
on their website.

Can I use MEDVi with HSA
or FSA funds?

Yes. Since GLP-1 medications are prescription drugs for a medical
condition (obesity), they generally qualify for HSA/FSA reimbursement.
You’ll need to save receipts and documentation for your FSA/HSA
administrator.

Final Verdict: Is MEDVi
Right for You?

MEDVi operates in a complicated intersection of affordability,
accessibility, and regulatory ambiguity. The service successfully
provides weight loss medications to thousands of customers at a fraction
of brand-name costs, but comes with trade-offs that prospective users
must carefully weigh.

MEDVi Makes Sense For:

• Budget-conscious individuals who can’t afford $1,000+ brand-name
  prices and lack insurance coverage
• People comfortable with compounding trade-offs who understand
  they’re choosing cost savings over FDA approval
• Those seeking accessible weight loss support without navigating
  insurance pre-authorizations
• Patients with BMI ≥30 or ≥27 with weight-related health
  conditions

Consider Alternatives If:

• You have insurance coverage that may pay for Wegovy or Zepbound
  (pursue brand-name first)
• You prioritize FDA oversight and comprehensive quality assurance
  over cost savings
• You’re risk-averse regarding medication safety and prefer
  established approval processes
• You need strong customer service and transparent refund
  policies

Action Steps for Interested
Readers

If you’re considering MEDVi:

1. Research current FDA guidance on compounded GLP-1s
   at FDA.gov
2. Check brand-name pricing through Ro, NovoCare, or
   your insurance to compare true costs
3. Read current Reddit discussions in
   r/tirzepatidecompound for recent customer experiences
4. Clarify refund policies in writing before
   committing to treatment
5. Consult your primary care physician about whether
   compounded GLP-1s are appropriate for your situation
6. Inspect medication upon arrival for proper
   refrigeration and clear labeling
7. Report any concerns to the FDA through MedWatch if
   you experience problems

The compounded GLP-1 market remains in flux, with ongoing FDA
enforcement actions and evolving regulations. MEDVi is one option in a
field of imperfect choices: expensive FDA-approved medications or
affordable compounded alternatives with less oversight.

For many cash-paying patients, compounded options like MEDVi may be
the only financially accessible path to GLP-1 therapy. For others with
insurance or lower risk tolerance, brand-name medications offer greater
assurance. There’s no universally “right” answer, only informed
decisions based on individual circumstances, priorities, and risk
tolerance.

---

Medical Disclaimer: This article is for
informational purposes only and does not constitute medical advice.
Consult with a qualified healthcare provider before starting any weight
loss medication. Individual results and experiences may vary.

Last Updated: February 25, 2026